Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406585200 on July 22, 2004

J. Biol. Chem., Vol. 279, Issue 39, 40529-40535, September 24, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/39/40529    most recent
M406585200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muhlethaler-Mottet, A.
Right arrow Articles by Reith, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muhlethaler-Mottet, A.
Right arrow Articles by Reith, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The S Box of Major Histocompatibility Complex Class II Promoters Is a Key Determinant for Recruitment of the Transcriptional Co-activator CIITA*

Annick Muhlethaler-Mottet{ddagger}§, Michal Krawczyk{ddagger}, Krzysztof Masternak{ddagger}, Charalambos Spilianakis||**, Androniki Kretsovali||, Joseph Papamatheakis||, and Walter Reith{ddagger}{ddagger}{ddagger}

From the {ddagger}University of Geneva Medical School, Department of Pathology and Immunology, Centre Médical Universitaire, 1 rue Michel-Servet, CH-1211, Geneva, Switzerland and the ||Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology, Vasilika Vouton, Heraklion 71110, Crete

Tightly regulated expression of major histocompatibility complex (MHC) class II genes is critical for the immune system. A conserved regulatory module consisting of four cis-acting elements, the W, X, X2 and Y boxes, controls transcription of MHC class II genes. The X, X2, and Y boxes are bound, respectively, by RFX, CREB, and NF-Y to form a MHC class II-specific enhanceosome complex. The latter constitutes a landing pad for recruitment of the transcriptional co-activator CIITA. In contrast to the well defined roles of the X, X2, and Y boxes, the role of the W region has remained controversial. In vitro binding studies have suggested that it might contain a second RFX-binding site. We demonstrate here by means of promoter pull-down assays that the most conserved subsequence within the W region, called the S box, is a critical determinant for tethering of CIITA to the enhanceosome complex. Binding of CIITA to the enhanceosome requires both integrity of the S box and a remarkably stringent spacing between the S and X boxes. Even a 1–2-base pair change in the native S-X distance is detrimental for CIITA recruitment and promoter function. In contrast to current models, binding of RFX to a putative duplicated binding site in the W box is thus not required for either CIITA recruitment or promoter activity. This paves the way for the identification of novel factors mediating the contribution of the S box to the activation of MHC class II promoters.


Received for publication, June 14, 2004 , and in revised form, July 14, 2004.

* This work was supported by the Swiss National Science Foundation, by the Swiss Commission pour la Technologie et de l'Innovation, and by a contribution from NovImmune S.A. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by the Marie Heim-Vögtlin Foundation. Present address: Onco-hematology Research Unit, Pediatrics, University Hospital of Vaud, CHUV, CH-1011, Lausanne, Switzerland.

Present address: NovImmune S.A., 64 avenue de la Roseraie, CH-1211, Geneva, Switzerland.

** Present address: Section of Immunobiology, Yale School of Medicine, 300 Cedar St., New Haven, CT 06520.

{ddagger}{ddagger} To whom correspondence should be addressed: University of Geneva Medical School, CMU, 1 rue Michel-Servet, CH-1211, Geneva, Switzerland. Tel.: 41-22-379-56-66; Fax: 41-22-379-57-46; E-mail: walter.reith{at}medecine.unige.ch.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Krawczyk, E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, E. Barras, and W. Reith
Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes
Nucleic Acids Res., January 28, 2007; 35(2): 595 - 605.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Krawczyk, K. Masternak, M. Zufferey, E. Barras, and W. Reith
New Functions of the Major Histocompatibility Complex Class II-Specific Transcription Factor RFXANK Revealed by a High-Resolution Mutagenesis Study
Mol. Cell. Biol., October 1, 2005; 25(19): 8607 - 8618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement